TipRanks
Advertisement
Advertisement

HK:2526 Stock Latest News

Hangzhou Diagens Biotech Shareholders Overwhelmingly Approve 2026 Incentive Scheme at EGM
Company AnnouncementsHangzhou Diagens Biotech Shareholders Overwhelmingly Approve 2026 Incentive Scheme at EGM
6d ago
2526
Diagens Biotech Strikes AI Imaging Partnership to Build Zhejiang Cloud Diagnostic Platform
PremiumCompany Announcements
Diagens Biotech Strikes AI Imaging Partnership to Build Zhejiang Cloud Diagnostic Platform
25d ago
2526
Hangzhou Diagens Seeks Approval for New 2026 Share Incentive Scheme
PremiumCompany Announcements
Hangzhou Diagens Seeks Approval for New 2026 Share Incentive Scheme
26d ago
2526
Hangzhou Diagens Added to Key Hang Seng Indexes, Gains Stock Connect Access
PremiumCompany Announcements
Hangzhou Diagens Added to Key Hang Seng Indexes, Gains Stock Connect Access
1M ago
2526
Hangzhou Diagens Biotechnology Announces Unaudited Interim Results for First Half of 2026
PremiumCompany Announcements
Hangzhou Diagens Biotechnology Announces Unaudited Interim Results for First Half of 2026
2M ago
2526
Hangzhou Diagens Biotech Sets Board Meeting to Approve 2026 Interim Results and Potential Dividend
PremiumCompany AnnouncementsHangzhou Diagens Biotech Sets Board Meeting to Approve 2026 Interim Results and Potential Dividend
2M ago
2526
Hangzhou Diagens Wins Strong Shareholder Approval for Business Scope Change
Premium
Company Announcements
Hangzhou Diagens Wins Strong Shareholder Approval for Business Scope Change
3M ago
2526
Premium
Company Announcements
Hangzhou Diagens Broadens Business Scope Into AI, Data and Telecom Services
3M ago
2526
PremiumCompany Announcements
Hangzhou Diagens Biotech Calls EGM to Revise Business Scope and Articles
3M ago
2526
PremiumCompany Announcements
Hangzhou Diagens Biotechnology Sets July 23 Date for Extraordinary General Meeting
3M ago
2526
PremiumCompany Announcements
Hangzhou Diagens Shareholders Unanimously Approve AGM Resolutions and Capital Mandates
3M ago
2526
PremiumCompany Announcements
Hangzhou Diagens Biotech Calls Hybrid 2025 AGM to Approve Financials and Capital Mandates
4M ago
2526
PremiumCompany AnnouncementsDiagens Wins Landmark Class III Approval for AI Chromosome Analysis System
5M ago
2526
Premium
Company Announcements
Hangzhou Diagens Bio Plans Share Incentive Scheme to Align Talent and Investors
5M ago
2526
Premium
Company Announcements
Hangzhou Diagens BioTech to Revise Articles After Hong Kong IPO
5M ago
2526
PremiumCompany AnnouncementsHangzhou Diagens Biotech Sets Timetable for Release of 2025 Annual Results
6M ago
2526

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >